Strategies to Extend Thrombolytic Time Window for Ischemic Stroke Treatment: An Unmet Clinical Need
Ike dela Peña, Cesar Borlongan, Guofang Shen, Willie Davis
J Stroke. 2017;19(1):50-60.   Published online 2017 Jan 31     DOI: https://doi.org/10.5853/jos.2016.01515
Citations to this article as recorded by Crossref logo
Development of a reactive oxygen species-sensitive nitric oxide synthase inhibitor for the treatment of ischemic stroke
Kevin M. Nash, Isaac T. Schiefer, Zahoor A. Shah
Free Radical Biology and Medicine.2018; 115: 395.     CrossRef
Thrombolysis in stroke patients: Comparability of point-of-care versus central laboratory international normalized ratio
Ramona C. Dolscheid-Pommerich, Sarah Dolscheid, Lars Eichhorn, Birgit Stoffel-Wagner, Ingo Graeff, Hugo ten Cate
PLOS ONE.2018; 13(1): e0190867.     CrossRef
Early Treatment with Poly(ADP-Ribose) Polymerase-1 Inhibitor (JPI-289) Reduces Infarct Volume and Improves Long-Term Behavior in an Animal Model of Ischemic Stroke
Youngchul Kim, Young Seo Kim, Hyun Young Kim, Min-Young Noh, Ji Young Kim, Young-Jun Lee, Jeongmin Kim, Jiseon Park, Seung Hyun Kim
Molecular Neurobiology.2018;[Epub]     CrossRef
Experimental models of focal and multifocal cerebral ischemia: a review
Kristy L. Meadows
Reviews in the Neurosciences.2018;[Epub]     CrossRef
Stroke Cytoprotection: Can Repeating History with New Expectations Really Be the Path to Success in Stroke Research?
Paul A. Lapchak, Victor V. Uteshev
Translational Stroke Research.2017; 8(2): 104.     CrossRef
Leukoaraiosis as an outcome predictor in the acute and subacute phases of stroke
Fabio Fierini, Anna Poggesi, Leonardo Pantoni
Expert Review of Neurotherapeutics.2017; 17(10): 963.     CrossRef
Adjunctive Therapy Approaches for Ischemic Stroke: Innovations to Expand Time Window of Treatment
Talia Knecht, Jacob Story, Jeffrey Liu, Willie Davis, Cesar Borlongan, Ike dela Peña
International Journal of Molecular Sciences.2017; 18(12): 2756.     CrossRef